Where does Genesys Spine rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genesys Spine ranks #16,049 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genesys Spine hold?

Genesys Spine holds 18 US utility patents granted between 2015 and 2024, spanning 2 technology areas.

What is Genesys Spine's Innovation Score?

Genesys Spine has an Innovation Score of 33.3 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Genesys Spine focus on?

Genesys Spine's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents, ranking #1,451 of 7,127 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Genesys Spine's patent grant rate increasing or decreasing?

Genesys Spine's recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Genesys Spine's patents?

Genesys Spine's patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genesys Spine patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Genesys Spine

USPTO PatentsView assignee record - 18 granted patents across 2 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genesys ranks #16,049 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 2 technology areas.

#16,049
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.3/100): 16.3
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16049 · US Corporation #16,049 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,049/49,997
PHOTO-FINISH Galaxy Therapeutics
CPC-NARROW A61B · 2 areas
INNOV-THIN 33.3/100
CLAIMS-RICH 16.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Galaxy Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Genesys’s 33.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (31%) Velocity 8.3 pts (25%) Breadth 5.0 pts (15%) Claim depth 9.8 pts (29%)

Qualcomm Incorporated · highest

85
Genesys Spine · this assignee

33
3D Lighting… · lowest

7

What this shows Genesys's Innovation Score is 33.3/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Genesys?

Each dot is one of Genesys’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genesys’s own 16.3 claims/patent is at or below the 17.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Genesys vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Genesys's grants concentrate

Genesys Spine is a focused PatentsView assignee: 2 CPC subclasses with 66.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2017. By volume, Genesys sits between Galaxy Therapeutics, Inc. and Good Start Genetics, Inc..

Genesys's three-year grant acceleration

Genesys Spine shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Galaxy Therapeuti…

18
Gbatteries Energy…

18
Geigtech East Bay

18
General Dynamics…

18
Giftya

18
Gigadevice Semico…

18
Glofish

18
Good Start Geneti…

18
Genesys Spine ◀

18

What this shows Genesys holds 18 patents at rank #16,057, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genesys

By rank, the assignees closest to #16,057 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Genesys's primary technology class.

Genesys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Genesys Spine patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	27.8%
2017	1	5.6%
2018	3	16.7%
2019	1	5.6%
2020	2	11.1%
2021	1	5.6%
2022	1	5.6%
2023	1	5.6%
2024	3	16.7%

Which technologies does Genesys Spine patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Genesys Spine's patent record in context - here's where to go next.

Genesys Spine's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 66.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #16,049 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Genesys Spine against Galaxy Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.